A Benefit Transfer Toolkit for Fish, Wildlife, Wetlands, and Open Space

Resource /Energy Economics and Policy,

Gamma-Ray Observations of GRO J1655-40

The bright transient X-ray source GRO J1655-40 = XN Sco 1994 was observed by the OSSE instrument on the Compton Gamma Ray Observatory (GRO). Preliminary results are reported here. The initial outburst from GRO J1655-40 was detected by BATSE on 27 Jul 1994. OSSE observations were made in five separate viewing periods starting between 4 Aug 1994 and 4 Apr 1995. The first, third, and fifth observations are near the peak luminosity. In the second observation, the source flux had dropped by several orders of magnitude and we can only set an upper limit. The fourth observation is a weak detection after the period of maximum outburst. In contrast with other X-ray novae such as GRO J0422+32, the spectrum determined by OSSE is consistent with a simple power law over the full range of detection, about 50 - 600 keV. The photon spectral index is in the range of -2.5 to 2.8 in all of the observations. We set an upper limit on fractional rms variation \u3c5% in the frequency range 0.01 – 60 Hz. No significant narrow or broad line features are observed at any energy

A method for localizing wing flow separation at stall to alleviate spin entry tendencies

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/76908/1/AIAA-1978-1476-516.pd

Magnetic flux flow and superconductor stabilization Quarterly report, 1 Jan. - 31 Mar. 1968

Magnetic flux flow and stability of superconducting niobium titanium strip

Molecular signature of organic nitrogen in septic-impacted groundwater

Author Posting. © The Author(s), 2014. This is the author's version of the work. It is posted here by permission of Royal Society of Chemistry for personal use, not for redistribution. The definitive version was published in Environmental Science: Processes & Impacts 16 (2014):2400-2407, doi:10.1039/C4EM00289J.Dissolved inorganic and organic nitrogen levels are elevated in aquatic systems due to anthropogenic activities. Dissolved organic nitrogen (DON) arises from various sources, and its impact could be more clearly constrained if specific sources were identified and if the molecular level composition of DON were better understood. In this work, the pharmaceutical carbamazepine was used to identify septic-impacted groundwater in a coastal watershed. Using ultrahigh resolution mass spectrometry data, the nitrogen-containing features of the dissolved organic matter in septic-impacted and non-impacted samples were compared. The septic impacted groundwater samples have a larger abundance of nitrogen-containing formulas. Impacted samples have additional DON features in the regions ascribed as ‘protein-like’ and ‘lipid-like’ in van Krevelen space and have more intense nitrogen-containing features in a specific region of a carbon versus mass plot. These features are potential indicators of dissolved organic nitrogen arising from septic effluents, and this work suggests that ultrahigh resolution mass spectrometry is a valuable tool to identify and characterize sources of DON.The Deep Ocean Exploration and Coastal Ocean Institutes at WHOI and the University of Minnesota Institute on the Environment are thanked for financial support.2015-02-0

Alleviation of Spin-Entry Tendencies through Localization of Wing-Flow Separation

Studies have been made on several wing leading-edge modifications applicable at present to single-engine light aircraft, which produce stabilizing vortices at stall and beyond. These vortices have the effect of fixing the stall pattern of the wing such that the various portions of the wing upper surface stall nearly symmetrically. The lift coefficient produced is maintained at a high level to angles of attack significantly above the stall angle of the unmodified wing, and the divergence in roll usually is reduced to a controllable level. It is hypothesized that these characteristics will help prevent inadvertent spin entry after a stall. Results are presented from recent large-scale wind-tunnel tests of a typical light aircraft, both with and without the modifications. The data indicate (hot the static stall and poststall characteristics of this aircraft, in a typical landing-approach condition, are noticeably improved when it suitable leading-edge modification is employed; and also that no appreciable aerodynamic penalties are evident in the normal flight envelope

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.

Agents capable of reversing P-glycoprotein-associated multidrug resistance have usually failed to enhance chemotherapy activity in patients with solid tumours. Based on its toxicity profile and experimental potency, dexverapamil, the R-enantiomer of verapamil, is considered to be promising for clinical use as a chemosensitizer. The purpose of this early phase II trial was to evaluate the effects of dexverapamil on epirubicin toxicity, activity and pharmacokinetics in patients with metastatic breast cancer. A two-stage design was applied. Patients first received epirubicin alone at 120 mg m(-2) i.v. over 15 min, repeated every 21 days. Patients with refractory disease continued to receive epirubicin at the same dose and schedule but supplemented with oral dexverapamil 300 mg every 6 h x 13 doses. The Gehan design was applied to the dexverapamil/epirubicin cohort of patients. Thirty-nine patients were entered on study, 25 proceeded to receive epirubicin plus dexverapamil. Dexverapamil did not increase epirubicin toxicity. The dose intensity of epirubicin was similar when used alone or with dexverapamil. In nine intrapatient comparisons, the area under the plasma concentration-time curve (AUC) of epirubicin was significantly reduced by dexverapamil (mean 2968 vs 1901 microg ml[-1] h[-1], P= 0.02). The mean trough plasma levels of dexverapamil and its major metabolite nor-dexverapamil were 1.2 and 1.5 microM respectively. The addition of dexverapamil to epirubicin induced partial responses in 4 of 23 patients evaluable for tumour response (17%, CI 5-39%, s.e.P 0.079). The remissions lasted 3, 8, 11 and 11+ months. These data suggest that the concept of enhancing chemotherapy activity by adding chemosensitizers may function not only in haematological malignancies but also in selected solid tumours. An increase in the AUC and toxicity of cytotoxic agents does not seem to be a prerequisite for chemosensitizers to enhance anti-tumour activity

Older mothers produce more successful daughters

Acknowledgements Marmots were studied under UCLA research protocol ARC 2001-191-01 (approved by the UCLA Animal Care Committee on 13 May 2002 and renewed annually). Permits were issued by the Colorado Division of Wildlife. We are thankful to all marmoteers who contributed to data collection. S.B.K. was supported by the Natural Environment Research Council, J.G.A.M. by a Marie-Curie Fellowship, and D.T.B by the National Geographic Society, UCLA (Faculty Senate and the Division of Life Sciences), a Rocky Mountain Biological Laboratory research fellowship, and the NSF (IDBR-0754247, DEB1119660 and DEB-1557130 to D.T.B., and DBI 0242960, DBI-0731346 and REU1226713 to the Rocky Mountain Biological Laboratory).Peer reviewedPostprin

Electrochemically-triggered spatially and temporally resolved multi-component gels

Spatial control over gelation with low molecular weight gelators is possible using an electrochemically-driven pH triggering method. Gelation occurs at the electrode surface. We show here that composition control in multi-component low molecular weight hydrogels can also be achieved, allowing simultaneous spatial, temporal and compositional control